STK11 and lung carcinoma: Genetically engineered mouse models have shown that the loss of liver kinase B1 (LKB1, also known as serine/threonine kinase (STK11)) can lead to lineage plasticity and SCC transformation in Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) mutant lung cancers [70].